Send feedback

ITGA3 p.Arg76Gln

c.227G>A · rs201210478 · VCV2048565

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 3 submitters
AlphaMissense
likely benign
0.0737 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.012%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome

Computational evidence

Protein change
AlphaMissense0.0737likely benign
REVEL0.149moderately benign-leaning
SaProtLLR -7.45tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -0.12GERP -1.8, phastCons 0.068
Regional constrainto/e 0.67unconstrained · MANE · 18 kb · p 5.2e-14 · regional, not allelic
Overall
CADD16.74PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.012% European (non-Finnish) · 142/1,179,678 alleles
Filtering AF 0.0104% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00981%
Overall 0.0124% 200/1,612,606 alleles · ultra-rare exomes 179/1,460,474 · genomes 21/152,132 · joint denominator
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.0739% 1,353
European (non-Finnish)grpmax 0.012% 8,308
Remaining individualsnot grpmax-eligible 0.00801% 12,482
Ashkenazi Jewishnot grpmax-eligible 0.00338% 29,586
East Asian 0.00223% 44,834
South Asian 0.0022% 45,355
Admixed American 0.00167% 59,928
African / African-American 0.00133% 74,956

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ITGA3
Protein
p.Arg76Gln
Coding
c.227G>A
MANE Select
NM_002204
dbSNP
rs201210478
Type
single nucleotide variant
Location
chr17:50064097 (GRCh38)
Gene constraint
LOEUF 0.69 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 83.88
Full ITGA3 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome (Orphanet):

Inheritance
Autosomal recessive
Onset
Infancy, Neonatal

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/itga3-p-arg76gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown